227. オスラー病 Osler disease Clinical trials / Disease details

臨床試験数 : 56 / 薬物数 : 72 - (DrugBank : 21) / 標的遺伝子数 : 23 - 標的パスウェイ数 : 136

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03227263 (ClinicalTrials.gov)	September 28, 2017	21/7/2017	BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hered ...	BABH Study: Efficacy and Safety of Bevacizumab on Severe Bleedings Associated With Hemorrhagic Hered ...	Rendu Osler Disease;Telangiectasia, Hereditary Hemorrhagic	Drug: Bevacizumab;Drug: sodium chloride 0.9%	Hospices Civils de Lyon	NULL	Completed	18 Years	N/A	All	24	Phase 3	France
2	EUCTR2009-018049-19-AT (EUCTR)	13/12/2010	23/11/2010	A randomized double blind placebo controlled trial of intranasal submucosal bevacizumab in hereditar ...	A randomized double blind placebo controlled trial of intranasal submucosal bevacizumab in hereditar ...	epistaxis	Trade Name: AVASTIN 25 mg/ml - Konzentrat zur Herstellung einer Infusionsloesung INN or Proposed INN: ...	Medizinische Universität Wien,Univ.Klinik f.Hals-, Nasen- und Ohrenkrankheiten	NULL	Not Recruiting			Female: yes Male: yes	30		Austria

First Previous1Next Last